These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9601155)

  • 21. Physician- and nurse-reported effects of intravenous hydration therapy on symptoms of terminally ill patients with cancer.
    Morita T; Shima Y; Miyashita M; Kimura R; Adachi I;
    J Palliat Med; 2004 Oct; 7(5):683-93. PubMed ID: 15588360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Midwifery: The Role of Proctoclysis (Rectal Fluid Infusion).
    Reid A
    Midwifery Today Int Midwife; 2016; (118):50-1. PubMed ID: 27464408
    [No Abstract]   [Full Text] [Related]  

  • 23. Hypodermoclysis (subcutaneous infusion) effective mode of treatment of dehydration in long-term care patients.
    Arinzon Z; Feldman J; Fidelman Z; Gepstein R; Berner YN
    Arch Gerontol Geriatr; 2004; 38(2):167-73. PubMed ID: 14698495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypodermoclysis for control of dehydration in terminal-stage cancer.
    Cerchietti L; Navigante A; Sauri A; Palazzo F
    Int J Palliat Nurs; 2000 Sep; 6(8):370-4. PubMed ID: 12411847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Artificial nutrition and hydration in terminally ill patients with advanced dementia: opinions and correlates among Italian physicians and nurses.
    Valentini E; Giantin V; Voci A; Iasevoli M; Zurlo A; Pengo V; Maggi S; Pegoraro R; Catarini M; Andrigo M; Storti M; Manzato E
    J Palliat Med; 2014 Oct; 17(10):1143-9. PubMed ID: 25188766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Re: Biochemical dehydration and fluid retention symptoms in terminally ill cancer patients whose death is impending.
    Morita T; Ichiki T; Tsunoda J; Inoue S; Chihara S
    J Palliat Care; 1998; 14(4):60-1. PubMed ID: 9893401
    [No Abstract]   [Full Text] [Related]  

  • 27. [Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial].
    Nijssen EC; Rennenberg RJ; Nelemans PJ; Essers BA; Janssen MM; Vermeeren MA; van Ommen V; Wildberger JE
    Ned Tijdschr Geneeskd; 2018; 161():D1734. PubMed ID: 29328007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nutrition and hydration for terminal cancer patients in Taiwan.
    Chiu TY; Hu WY; Chuang RB; Chen CY
    Support Care Cancer; 2002 Nov; 10(8):630-6. PubMed ID: 12436222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proctoclysis: emergency rectal fluid infusion.
    Tremayne V
    Nurs Stand; 2009 Sep 23-29; 24(3):46-8. PubMed ID: 19856644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perceptions and decision-making on rehydration of terminally ill cancer patients and family members.
    Morita T; Tsunoda J; Inoue S; Chihara S
    Am J Hosp Palliat Care; 1999; 16(3):509-16. PubMed ID: 10661058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of intravenous fluid infusion on blood and urine parameters of hydration and on state of consciousness in terminal cancer patients.
    Waller A; Hershkowitz M; Adunsky A
    Am J Hosp Palliat Care; 1994; 11(6):22-7. PubMed ID: 7893564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. When they stop drinking-examining end-of-life hydration practices and death rattle occurrence.
    Dayan D; Menahem S; Shvartzman P
    Support Care Cancer; 2021 Jan; 29(1):179-185. PubMed ID: 32328774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nurse views of the adequacy of decision making and nurse distress regarding artificial hydration for terminally ill cancer patients: a nationwide survey.
    Miyashita M; Morita T; Shima Y; Kimura R; Takahashi M; Adachi I
    Am J Hosp Palliat Care; 2007 Dec-2008 Jan; 24(6):463-9. PubMed ID: 17601838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Artificial hydration in the terminally ill patient.
    Boland E; Johnson M; Boland J
    Br J Hosp Med (Lond); 2013 Jul; 74(7):397-401. PubMed ID: 24159642
    [No Abstract]   [Full Text] [Related]  

  • 35. Attitudes of Japanese physicians toward terminal dehydration: a nationwide survey.
    Morita T; Shima Y; Adachi I;
    J Clin Oncol; 2002 Dec; 20(24):4699-704. PubMed ID: 12488416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial.
    Nijssen EC; Rennenberg RJ; Nelemans PJ; Essers BA; Janssen MM; Vermeeren MA; Ommen VV; Wildberger JE
    Lancet; 2017 Apr; 389(10076):1312-1322. PubMed ID: 28233565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dehydration: burden or benefit to the dying patient?
    Sutcliffe J; Holmes S
    J Adv Nurs; 1994 Jan; 19(1):71-6. PubMed ID: 8138633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proctoclysis for hydration.
    Needham D
    Lancet; 1995 Mar; 345(8949):596. PubMed ID: 7776814
    [No Abstract]   [Full Text] [Related]  

  • 39. Hypodermoclysis: an alternative infusion technique.
    Sasson M; Shvartzman P
    Am Fam Physician; 2001 Nov; 64(9):1575-8. PubMed ID: 11730312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Indications and practice of artificial hydration for terminally ill cancer patients.
    Nakajima N; Satake N; Nakaho T
    Curr Opin Support Palliat Care; 2014 Dec; 8(4):358-63. PubMed ID: 25211496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.